ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions

ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.